![Yu Shi Feng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Yu Shi Feng formerly worked at Capricor Therapeutics, Inc., as Vice President-Regulatory Affairs from 2023 to 2025 and Codiak BioSciences, Inc., as Vice President-Regulatory Affairs.
Dr. Feng received his doctorate degree from the University of Minnesota and undergraduate degree from Ocean University of China.
Former positions of Yu Shi Feng
| Companies | Position | End |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | General Counsel | 10/01/2025 |
| CODIAK BIOSCIENCES | General Counsel | - |
Training of Yu Shi Feng
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Ocean University of China
 Ocean University of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
- Stock Market
- Insiders
- Yu Shi Feng
